Empowering the next evolution in degradation platforms.
Automera is pioneering a new frontier in autophagy-driven degradation.
Through cutting-edge computational chemistry, artificial intelligence, and quantum molecular dynamics, our platform excels in designing chimeric small molecules with dual-binding capabilities. These molecules effectively target both autophagy and the specific disease target, unleashing a powerful approach to combat diseases with unprecedented precision and efficiency.
Whether it is in cancer, inflammation, or the central nervous system, our versatile platform has the capability to attack challenging-to-treat targets wherever they may exist.